Larvol Delta - Sonelokimab-quotVELATEEN-met-its-endpoint-VELATEEN-is-the-only-dedicated-study-in-adolescent-HS-to-date-and-demonstrates-breakthrough-efcacy-with-SLK--almost-70-of-adolescents-achieve-HiSCR75-at-Week-24-45-reach-HiSCR10quot-Hidradenitis-Suppurativa